CY1935A - Novel vaccine and method therefor - Google Patents

Novel vaccine and method therefor

Info

Publication number
CY1935A
CY1935A CY193591A CY193591A CY1935A CY 1935 A CY1935 A CY 1935A CY 193591 A CY193591 A CY 193591A CY 193591 A CY193591 A CY 193591A CY 1935 A CY1935 A CY 1935A
Authority
CY
Cyprus
Prior art keywords
method therefor
novel vaccine
detoxified
pertussis toxin
vaccine
Prior art date
Application number
CY193591A
Other languages
English (en)
Inventor
Carine Capiau
Jean Petre
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of CY1935A publication Critical patent/CY1935A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
CY193591A 1990-02-12 1991-02-07 Novel vaccine and method therefor CY1935A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47909890A 1990-02-12 1990-02-12
PCT/EP1991/000257 WO1991012020A1 (fr) 1990-02-12 1991-02-07 Nouveau vaccin et procede d'obtention de celui-ci

Publications (1)

Publication Number Publication Date
CY1935A true CY1935A (en) 1991-02-07

Family

ID=23902647

Family Applications (1)

Application Number Title Priority Date Filing Date
CY193591A CY1935A (en) 1990-02-12 1991-02-07 Novel vaccine and method therefor

Country Status (16)

Country Link
EP (1) EP0515415B1 (fr)
JP (1) JP3035712B2 (fr)
KR (1) KR100202052B1 (fr)
AT (1) ATE129159T1 (fr)
AU (1) AU646019B2 (fr)
CA (1) CA2075711C (fr)
CY (1) CY1935A (fr)
DE (1) DE69113991T2 (fr)
DK (1) DK0515415T3 (fr)
ES (1) ES2080941T3 (fr)
GR (1) GR3018440T3 (fr)
IE (1) IE70672B1 (fr)
NZ (1) NZ237069A (fr)
PT (1) PT96723B (fr)
WO (1) WO1991012020A1 (fr)
ZA (1) ZA91947B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG48365A1 (en) 1992-05-23 1998-04-17 Smithkline Beecham Biolog Combined vaccines comprising hepatitis b surface antigen and other antigens
GB9216351D0 (en) * 1992-07-31 1992-09-16 Wellcome Found Vaccine production
WO2000012124A1 (fr) * 1998-09-01 2000-03-09 Elan Corporation, Plc Compositions de vaccin oral
AU769539B2 (en) * 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
GB0313916D0 (en) 2003-06-16 2003-07-23 Glaxosmithkline Biolog Sa Vaccine composition
BR112014017898B1 (pt) 2012-02-01 2021-10-13 Glaxosmithkline Biologicals S.A. Processo de fermentação
AU2013301312A1 (en) 2012-08-06 2015-03-19 Glaxosmithkline Biologicals S.A. Method for eliciting in infants an immune response against RSV and B. pertussis
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
WO2014135651A1 (fr) 2013-03-08 2014-09-12 Crucell Holland B.V. Vaccin acellulaire contre la coqueluche
US9849066B2 (en) 2013-04-24 2017-12-26 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
MX2016001695A (es) 2013-08-05 2016-05-02 Glaxosmithkline Biolog Sa Composiciones inmunogenas de combinacion.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4070454A (en) * 1973-05-04 1978-01-24 Agence Nationale De Valorisation De La Recherche (Anvar) Vaccines, the process for preparing the same and the applications thereof
JPS5750925A (en) * 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
GB8601279D0 (en) * 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
US4888169A (en) * 1986-10-14 1989-12-19 Norden Laboratories, Inc. Bordetella Bronchiseptica vaccine
WO1990009444A1 (fr) * 1989-02-10 1990-08-23 Genesit Oy Procede de production de sous-unites de toxine de coqueluche

Also Published As

Publication number Publication date
EP0515415A1 (fr) 1992-12-02
IE910424A1 (en) 1991-08-14
HK1004524A1 (en) 1998-11-27
CA2075711C (fr) 2000-11-07
ATE129159T1 (de) 1995-11-15
EP0515415B1 (fr) 1995-10-18
PT96723B (pt) 1998-07-31
AU646019B2 (en) 1994-02-03
JP3035712B2 (ja) 2000-04-24
ZA91947B (en) 1992-01-29
AU7211091A (en) 1991-09-03
WO1991012020A1 (fr) 1991-08-22
GR3018440T3 (en) 1996-03-31
DE69113991T2 (de) 1996-03-21
NZ237069A (en) 1993-07-27
ES2080941T3 (es) 1996-02-16
JPH05503936A (ja) 1993-06-24
DK0515415T3 (da) 1995-11-27
KR100202052B1 (ko) 1999-06-15
KR920703099A (ko) 1992-12-17
DE69113991D1 (de) 1995-11-23
CA2075711A1 (fr) 1991-08-13
IE70672B1 (en) 1996-12-11
PT96723A (pt) 1991-10-31

Similar Documents

Publication Publication Date Title
DE69022106D1 (de) Pertussistoxin-Mutanten, dieselbe produzierende Bordetella-Stämme und ihre Verwendung als Vakzin gegen Pertussis.
NO165478C (no) Fremgangsmaate for fremstilling av antigeniske preparater.
GR3018440T3 (en) Novel vaccine and method therefor.
EP0276516A3 (en) New oligosaccharides, immunogens and vaccines, and methods for preparing such oligosaccharides, immunogens and vaccines
GR870917B (en) Novel mehthod of preparing toxoid
NO872919D0 (no) Fremstilling av pertussis-toksin ved dyrkning av bodella pertussis.
YU303680A (en) Process for preparing benzofurnace derivatives
CY1934A (en) Process
CA2004206A1 (fr) Methodes de preparation de l'anatoxine coquelucheuse
ZA892908B (en) Pertussis toxoid vaccine
GR3017912T3 (en) Calicheamicinone, derivatives and analogs thereof and methods of making the same.
Prado et al. Diphtheria anatoxin industrial purification by gel filtration
RO74766A2 (fr) Procede de preparation d'un vaccin destine a l'immunisation des chevaux contre la rhinopneumonie
DK49685A (da) Fremgangsmaade til fremstilling af en modificeret levende pasteurella haemolytica vaccine